Predictors of haemoconcentration at delivery: association with low birth weight
- First Online:
To assess the factors associated with risk of haemoconcentration at delivery, such as initial haemoglobin levels and alterations in the HFE gene, and its effect on low birth weight in pregnant women supplemented with moderate doses of iron.
Case–control study nested in a longitudinal study conducted on 217 healthy pregnant women taking moderate iron supplementation and their newborns. Women were classified according to the risk of haemoconcentration at delivery, defined as Hb > 130 g/L. Each subject’s obstetric and clinical history, smoking habit, and iron biochemical parameters (haemoglobin (Hb), serum ferritin and transferrin saturation) were recorded at 1st, 2nd and 3rd trimester and at delivery. Polymorphisms of the HFE gene (C282Y, H63D and S65C) were also measured.
The average of iron supplementation of all the women was 43.9 mg/dia (geometric mean, 95 % CI: 43.6–44.1). Higher levels of Hb at early gestation and the presence of HFE mutations were associated with greater risk of haemoconcentration at delivery, adjusted odds ratios of 1.14 (95 % CI: 1.05–1.25) and 5.35 (95 % CI: 1.6–17.8). Haemoconcentration at delivery was associated with a greater risk of low birth weight, adjusted odd ratio of 11.48 (95 % CI: 1.13–116.6).
Moderate daily doses of supplementary iron may be harmful for foetal growth in women with alterations in HFE gene and who started pregnancy with good haemoglobin levels. Overall, this suggests the importance of determining a woman’s iron status early in her pregnancy in order to establish a more appropriate pattern of supplementation.
KeywordsPregnancy Haemoconcentration Iron status Iron supplementation HFE mutations Low birth weight
- 1.Bothwell TH (2000) Iron requirements in pregnancy and strategies to meet them. Am J Clin Nutr 72:257S–263SGoogle Scholar
- 3.Centers for Disease Control and Prevention (1998) Recommendations to prevent and control iron deficiency in the United States. MMWR Recomm Rep 47:1–29Google Scholar
- 4.Ministerio de Sanidad y consumo (2006) Guía para la prevención de defectos congénitos. Ministerio de Sanidad y Consumo, MadridGoogle Scholar
- 5.Stoltzfus R, Dreyfuss M (1998) Guidelines for the use of iron supplements to prevent and treat iron deficiency anaemia. INACG. ILSI Press, Washington, DCGoogle Scholar
- 6.WHO (2006) Iron and folate supplementation. Standards for maternal and neonatal care. Integrated Management of Pregnancy and Childbirth (IMPAC). World Health Organization, Geneva, pp 1–6Google Scholar
- 9.Papadopoulou E, Stratakis N, Roumeliotaki T, Sarri K, Merlo DF, Kogevinas M, Chatzi L (2012) The effect of high doses of folic acid and iron supplementation in early-to-mid pregnancy on prematurity and fetal growth retardation: the mother-child cohort study in Crete, Greece (Rhea study). Eur J Nutr. doi:10.1007/s00394-012-0339z Google Scholar
- 10.Peña-Rosas J, Viteri F (2009) Effects and safety of preventive oral iron or iron plus folic acid supplementation for women during pregnancy. Cochrane database of systematic reviewsGoogle Scholar
- 11.Casanueva E, Viteri F (2003) Iron and oxidative stress in pregnancy. J Nutr 133:1700S–1708SGoogle Scholar
- 12.Emamghorashi F, Heidari T (2004) Iron status of babies born to iron-deficient anaemic mothers in an Iranian hospital. East Mediterr Health J 10:808–814Google Scholar
- 14.Milman N, Bergholt T, Eriksen L, Byg K, Graudal N, Pedersen P, Hertz J (2005) Iron prophylaxis during pregnancy—how much iron is needed? A randomized dose- response study of 20–80 mg ferrous iron daily in pregnant women. Acta Obstet Gynecol Scand 84:238–247Google Scholar
- 17.Scholl TO (2005) Iron status during pregnancy: setting the stage for mother and infant. Am J Clin Nutr 81:1218S–1222SGoogle Scholar
- 21.Feder JN, Tsuchihashi Z, Irrinki A, Lee V, Mapa F, Lee VK, Mapa FA, Morikang E, Prass CE, Starnes SM, Wolff RK, Parkkila S et al (1997) The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression. J Biol Chem 272:14025–14028CrossRefGoogle Scholar
- 24.Hollingshead AB (2011) Four factor index of social status. Yale J Sociol 8:21–52Google Scholar
- 25.Gómez F, Simó JM, Camps J, Clivillé X, Bertran N, Ferré N, Bofill C, Joven J (2000) Evaluation of a particle-enhanced turbidimetric immunoassay for the measurement of ferritin: application to patients participating in an autologous blood transfusion program. Clin Biochem 33:191–196CrossRefGoogle Scholar
- 26.Fairbanks VF, Klee GG (1999) Biochemical aspects of haematology. In: Burtis CA, Ashwood ER (eds) Tietz textbook of clinical chemistry, 3rd edn. WB Saunders, Philadelphia, pp 1698–1705Google Scholar
- 27.WHO (2001) Iron deficiency anemia assessment prevention and control: a guide for program managers. World Health Organization, GenevaGoogle Scholar
- 29.Mura C, Raguenes O, Férec C (1999) HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood 93:2502–2505Google Scholar
- 30.WHO (1993) International statistical classification of diseases and related health problems. 10th revision. World Health Organization, GenevaGoogle Scholar
- 31.Carrillo SM, Pérez Guillén A, Hernández Hernández RA, Herrera Mogollón HA (2010) Anthropometric nutritional evaluation of the pregnant women and its relation with the product of the gestation. Nutr Hosp 25:832–837Google Scholar
- 32.Reinold C, Dalenius K, Smith B, Brindley P, Grummer-Strawn L (2011) Pregnancy nutrition surveillance 2009 report. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, USGoogle Scholar
- 39.Zimmermann MB (2008) Methods to assess iron and iodine status. Br J Nutr 99(Suppl 3):S2–S9Google Scholar